REPROS THERAPEUTICS INC.: cash_and_equivalents

Value{"amount": 17150000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2013-03-31)
Statuscurrent
EntityREPROS THERAPEUTICS INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001144204-13-027766 · Open the official SEC filing →
Retrieved: 2026-08-19T09:01:54.332042+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000897075/cash-and-equivalents/2013-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/b0052da1-b112-4457-bc2f-08f56b05e2c7

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies